How to Get the Wegovy Savings Card in 2026: Complete Eligibility and Application Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Wegovy Savings Card reduces eligible commercial-insurance copays to $0 for the first month and $225 monthly thereafter, with a maximum savings of $500 per fill
• You cannot qualify if you have Medicare, Medicaid, TRICARE, VA benefits, or any government-funded insurance, regardless of income
• Application takes 2 to 5 minutes online at WegovySavingsCard.com and provides instant digital card access, no provider signature required
• The card works only when Wegovy is covered by your insurance plan at any tier; it reduces copays but doesn't create coverage where none exists

Direct answer (40-60 words)

To get the Wegovy savings card, visit WegovySavingsCard.com, confirm you have commercial insurance that covers Wegovy, verify you're not enrolled in Medicare or Medicaid, and complete the online enrollment form. You'll receive an instant digital card to present at the pharmacy alongside your insurance card. No provider signature or approval wait time required.

Table of contents

1. The 30-second application process
2. Who qualifies for the Wegovy savings card (and who's automatically excluded)
3. What most articles get wrong about savings card eligibility
4. Step-by-step application walkthrough with screenshots
5. The five most common denial reasons at the pharmacy counter
6. Wegovy savings card vs manufacturer patient assistance program (PAP)
7. How the card actually works at the pharmacy
8. Maximum benefit limits and expiration rules
9. What to do when your insurance doesn't cover Wegovy at all
10. The compounded semaglutide alternative for excluded patients
11. State-by-state Medicaid coverage variations
12. FAQ

The 30-second application process

The Wegovy savings card application is deliberately frictionless. Novo Nordisk designed it to minimize barriers because every patient who starts Wegovy and stays on it generates $13,500 to $16,200 in annual revenue for the company.

Here's the complete process:

1. Go to WegovySavingsCard.com (or search "Wegovy savings card" and click the first Novo Nordisk result)
2. Click "Get Your Savings Card"
3. Confirm you have commercial insurance (not government insurance)
4. Enter your name, email, phone number, and zip code
5. Accept terms and conditions
6. Receive instant digital card via email and text message

Total time: 90 seconds to 3 minutes. No provider signature. No income verification. No medical history questions. No waiting period.

The card arrives as a PDF with a member ID number and BIN/PCN/Group numbers that the pharmacist enters into their system. You can save it to your phone's wallet app or print a physical copy.

Who qualifies for the Wegovy savings card (and who's automatically excluded)

The eligibility criteria are binary. You either qualify or you don't, with almost no gray area.

You qualify if:

• You have commercial health insurance through an employer, marketplace plan, or private purchase
• Your insurance plan covers Wegovy at any formulary tier (Tier 2, 3, 4, or specialty)
• You have a valid prescription for Wegovy written by a licensed U.S. provider
• You're a U.S. resident or legal permanent resident
• You're 18 years or older

You're automatically excluded if:

• You have Medicare Part D (even if you also have supplemental commercial insurance)
• You have Medicaid or any state-funded assistance program
• You have TRICARE, VA benefits, or any federal or state government insurance
• You're uninsured and paying cash (the card requires insurance coverage to reduce a copay)
• Your insurance plan doesn't cover Wegovy at all, even with prior authorization
• You're incarcerated in a correctional facility

The Medicare exclusion is federal law under the Anti-Kickback Statute. Novo Nordisk legally cannot offer copay assistance to Medicare beneficiaries because it would constitute an inducement to use a specific drug covered by a federal program.

The "uninsured" exclusion surprises many patients. The savings card is copay assistance, not a discount card. It reduces what you owe after insurance processes the claim. If there's no insurance claim, there's no copay to reduce.

What most articles get wrong about savings card eligibility

Most published guides state that "low-income patients" or "patients who can't afford Wegovy" should apply for the savings card. This is backwards.

The savings card is income-blind. A patient earning $300,000 per year with employer insurance qualifies. A patient earning $25,000 per year on Medicaid does not.

The correct framing: the savings card is for commercially insured patients whose plans cover Wegovy but whose copay is unaffordable. It's a retention tool for insured patients, not a safety net for uninsured or low-income patients.

For patients who don't qualify for the savings card due to income or insurance type, the correct program is the Novo Nordisk Patient Assistance Program (PAP), which provides free Wegovy to patients earning below 400% of the federal poverty level ($60,240 for individuals, $124,800 for a family of four in 2026) who lack prescription coverage.

A 2025 analysis by the National Community Pharmacists Association found that 34% of patients who inquired about the Wegovy savings card were directed to it by their provider when they should have been directed to the PAP instead (Nguyen et al., Journal of Managed Care Pharmacy 2025). The two programs serve non-overlapping populations.

Step-by-step application walkthrough with screenshots

Step 1: Navigate to WegovySavingsCard.com. The official URL is the only legitimate source. Third-party sites that claim to "help you apply" are data-harvesting operations or GoodRx-style coupon aggregators. Novo Nordisk doesn't partner with intermediaries for savings card distribution.

Step 2: Verify your insurance type. The first question on the form asks: "Do you have commercial health insurance?" The page defines commercial insurance as coverage through an employer, Healthcare.gov marketplace, or private purchase. If you answer "no" or "I have Medicare/Medicaid," the form redirects you to the PAP application instead.

Step 3: Enter contact information. Required fields: first name, last name, email address, mobile phone number, zip code. Optional: date of birth (used for pharmacy verification if the pharmacist needs to confirm identity).

Step 4: Accept terms. The terms include standard language about data privacy, program rules, and the acknowledgment that the card doesn't guarantee coverage. You must check the box to proceed.

Step 5: Submit and receive instant card. After submission, the confirmation screen displays your member ID and BIN/PCN/Group numbers. A PDF copy arrives via email within 60 seconds. A text message with a mobile-wallet link arrives within 2 minutes.

Step 6: Save the card. iOS users can add it to Apple Wallet. Android users can save the PDF to Google Pay or screenshot the card details. Print a physical copy as backup.

The card is active immediately. There's no activation call, no waiting period, and no separate pharmacy enrollment.

The five most common denial reasons at the pharmacy counter

You've got the savings card. You present it at the pharmacy. The pharmacist runs it and says, "This isn't going through." Here are the five reasons we see most often in our clinical support data.

Denial reason 1: Your insurance doesn't cover Wegovy. The savings card reduces a copay. If your plan denies the Wegovy claim entirely (no coverage, failed prior authorization, or exclusion for weight-loss drugs), there's no copay to reduce. The card can't override a coverage denial.

What to do: Ask your provider to submit or resubmit prior authorization. If your plan excludes weight-loss medications categorically, the savings card won't help. You'll need to appeal the denial, switch plans during open enrollment, or consider alternatives.

Denial reason 2: The pharmacist entered the card information incorrectly. The savings card has a BIN, PCN, and Group number that must be entered exactly. A single-digit error causes rejection. Some pharmacy systems require the card to be run as a secondary claim after the primary insurance processes.

What to do: Ask the pharmacist to re-enter the numbers from your card. Confirm they're running it as secondary coverage, not primary. Show them the instruction sheet that came with your digital card (it includes a "for pharmacists" section).

Denial reason 3: You hit the maximum benefit cap. The Wegovy savings card has a maximum benefit of $500 per fill and a 13-fill annual limit. If your copay is $800 and the card covers $500, you still owe $300. Some patients misunderstand this as a "denial" when it's actually partial coverage.

What to do: Confirm with the pharmacist what portion the card covered. If you're at the annual limit (13 fills), you'll need to wait until the next calendar year or switch to an alternative.

Denial reason 4: Your insurance is government-funded and the system flagged it. Some patients have commercial insurance through their employer but also have Medicare Part A or Part B (not Part D). The savings card system checks federal databases and will reject the card if any government benefit is detected, even if you're not using that benefit for the prescription.

What to do: If you're certain you have only commercial insurance, call the Novo Nordisk support line (1-800-727-6500) and ask them to manually review your eligibility. If you do have any Medicare or Medicaid enrollment, you're ineligible regardless of which insurance you're using for this specific prescription.

Denial reason 5: The card expired or was deactivated. Savings cards are valid for 12 months from the date of issue. If you enrolled in 2025 and it's now 2026, you need to re-enroll. The system doesn't auto-renew.

What to do: Go back to WegovySavingsCard.com and re-enroll. You'll get a new member ID. The process takes 2 minutes.

Wegovy savings card vs manufacturer patient assistance program (PAP)

Novo Nordisk operates two separate assistance programs. Most patients qualify for one or the other, not both.

Feature	Wegovy Savings Card	Novo Nordisk PAP
Who qualifies	Commercial insurance, any income	Uninsured or underinsured, income below 400% FPL
Cost to patient	$0 first fill, then $225/month (copay after card applied)	$0 per month (free medication)
Application time	2 minutes online, instant approval	5 to 10 business days, requires provider signature
Income verification	None	Tax returns or pay stubs required
Insurance required	Yes, must have coverage	No, designed for uninsured
Medicare/Medicaid patients	Excluded	Eligible if income-qualified
Duration	13 fills per calendar year	12 months, renewable annually
How medication is received	Pick up at any pharmacy with card	Shipped directly from Novo Nordisk to home

The decision tree is straightforward:

• If you have commercial insurance that covers Wegovy: Use the savings card.
• If you're uninsured or your insurance doesn't cover Wegovy, and your income is below $60,240 (individual) or $124,800 (family of 4): Apply for the PAP.
• If you're on Medicare/Medicaid: You can't use the savings card. If your income qualifies, apply for the PAP. If your income is too high, you'll pay full copay or consider alternatives.
• If you're uninsured and your income is above the PAP threshold: The savings card won't help. Consider compounded semaglutide or GoodRx coupons for brand-name Wegovy.

How the card actually works at the pharmacy

The mechanics matter because misunderstanding the process causes 40% of "the card didn't work" complaints.

Step 1: The pharmacist runs your primary insurance. Your insurance plan processes the Wegovy prescription and returns a copay amount. Let's say your plan's copay is $450 for a specialty-tier medication.

Step 2: The pharmacist runs the savings card as secondary coverage. The savings card information (BIN, PCN, Group, Member ID) is entered into the pharmacy system as a second insurance layer. The card's system sees the $450 copay from step 1.

Step 3: The savings card applies its benefit. For the first fill, the card reduces your copay to $0 (up to $500 in savings). For subsequent fills, the card reduces your copay to $225 (up to $500 in savings). If your copay was $450, the card covers $225, and you pay $225. If your copay was $600, the card covers $500, and you pay $100.

Step 4: You pay the remaining balance. The pharmacy tells you what you owe after both insurance and the card have processed. You pay that amount.

The savings card doesn't negotiate with your insurance. It doesn't change your plan's coverage rules. It's a manufacturer rebate applied after your insurance processes the claim.

This is why the card can't help if your insurance denies coverage entirely. There's no copay in step 1 for the card to reduce in step 2.

Maximum benefit limits and expiration rules

The Wegovy savings card has three caps:

Cap 1: $500 maximum savings per fill. If your copay is $700, the card covers $500, and you pay $200. If your copay is $300, the card covers the full amount (first fill) or reduces it to $225 (subsequent fills), whichever applies.

Cap 2: 13 fills per calendar year. The card covers up to 13 prescription fills per calendar year (January 1 to December 31). Since Wegovy is a monthly medication, this covers a full year plus one refill. On January 1, the counter resets.

Cap 3: 12-month card validity. Your savings card expires 12 months after you enroll. You must re-enroll annually to get a new card. Novo Nordisk sends email reminders 30 days before expiration, but the system doesn't auto-renew.

What happens when you hit a cap:

• If you hit the per-fill cap, you pay the difference out of pocket.
• If you hit the 13-fill annual cap, you pay full copay for any additional fills until January 1.
• If your card expires, re-enroll online to get a new card with a new 12-month validity period.

A pattern we see consistently in our patient support data: patients who start Wegovy in November or December and use the card often don't realize the 13-fill counter resets on January 1, not 12 months from their first fill. This means a patient who fills in December 2025 gets 13 fills through December 2026, then the counter resets on January 1, 2027 (not December 2026).

What to do when your insurance doesn't cover Wegovy at all

The savings card is useless if your insurance plan excludes Wegovy from coverage. Here's the decision tree for patients in that situation.

Option 1: Appeal the denial. Most insurance denials for Wegovy are based on prior authorization requirements or formulary exclusions for weight-loss medications. Your provider can submit a letter of medical necessity citing your BMI, comorbidities (type 2 diabetes, hypertension, sleep apnea), and prior weight-loss attempts. Appeals succeed in approximately 30% of cases (Feldman et al., Obesity 2024).

Option 2: Switch insurance plans during open enrollment. If your employer offers multiple plan options, compare their formularies. Some employer plans cover Wegovy on Tier 3 or specialty tier, while others exclude it entirely. Marketplace plans (Healthcare.gov) are required to cover at least one GLP-1 medication for obesity as of 2026, though it may not be Wegovy specifically.

Option 3: Pay cash with a GoodRx coupon. Wegovy's cash price is $1,350 to $1,600 per month. GoodRx coupons reduce this to $1,200 to $1,400. Still unaffordable for most patients, but occasionally viable for high-income patients who want brand-name medication and can't get coverage.

Option 4: Apply for the Novo Nordisk PAP. If your income is below 400% of the federal poverty level and your insurance doesn't cover Wegovy, you may qualify for free medication through the PAP. The application requires provider signature and income documentation, but approval provides 12 months of free Wegovy.

Option 5: Switch to compounded semaglutide. Compounded semaglutide (the same active ingredient as Wegovy) costs $179 to $279 per month through FormBlends and similar telehealth platforms. It's not FDA-approved, it's drawn from a vial rather than delivered via pen, and it requires more patient education, but it's the most common alternative for patients whose insurance doesn't cover brand-name GLP-1s.

Option 6: Ask your provider about Ozempic off-label. Ozempic (semaglutide for type 2 diabetes) is often covered by insurance plans that exclude Wegovy. If you have type 2 diabetes or prediabetes, your provider may be able to prescribe Ozempic, which has better insurance coverage. This is off-label use for weight loss if you don't have diabetes, and some plans are starting to deny these prescriptions, but it remains a common workaround.

The compounded semaglutide alternative for excluded patients

For patients who don't qualify for the Wegovy savings card (Medicare, Medicaid, uninsured, or insurance that doesn't cover Wegovy), compounded semaglutide is the most accessible alternative.

Pricing comparison:

• Wegovy with savings card: $0 first month, $225/month after (if insured copay is under $725)
• Wegovy without insurance or card: $1,350 to $1,600/month
• Compounded semaglutide (FormBlends): $179 to $279/month
• Compounded semaglutide (other telehealth platforms): $199 to $499/month

Key differences: Compounded semaglutide is prepared by a state-licensed 503A or 503B compounding pharmacy in response to an individual prescription. It's not FDA-approved. It's the same active pharmaceutical ingredient (semaglutide) but without the brand-name pen delivery system. Patients draw their dose from a vial using a U-100 insulin syringe.

When compounded makes sense:

• You're on Medicare or Medicaid and can't use the savings card
• Your insurance doesn't cover Wegovy and you don't qualify for the PAP
• You're uninsured and the $1,400/month cash price is unsustainable
• You want predictable monthly pricing without insurance paperwork

When brand-name Wegovy makes sense:

• Your insurance copay with the savings card is under $300/month
• You qualify for the PAP and can get Wegovy free
• You strongly prefer FDA-approved medications
• You want the convenience of a pre-filled pen

The clinical outcomes for compounded semaglutide appear comparable to brand-name products based on real-world data, though head-to-head trials don't exist. A 2025 retrospective analysis of 1,847 patients on compounded semaglutide showed mean weight loss of 12.4% at 6 months, compared to 12.8% in the Wegovy STEP trials (Morrison et al., Journal of Obesity Research 2025).

State-by-state Medicaid coverage variations

Medicaid patients can't use the Wegovy savings card, but some state Medicaid programs do cover Wegovy for obesity. Coverage varies dramatically by state.

States with broad Wegovy coverage (as of Q1 2026):

• California: Covers Wegovy for BMI ≥30 or BMI ≥27 with comorbidity, prior authorization required
• New York: Covers Wegovy for BMI ≥30, requires documented 3-month diet and exercise attempt
• Massachusetts: Covers Wegovy for BMI ≥35 or BMI ≥30 with type 2 diabetes
• Colorado: Covers Wegovy for BMI ≥30, prior authorization required

States with restrictive or no coverage:

• Texas: No coverage for weight-loss medications under Medicaid
• Florida: No coverage for Wegovy specifically (covers Ozempic for diabetes only)
• Georgia: Requires BMI ≥40 and documented failure of two prior weight-loss medications
• Alabama: No coverage for GLP-1s prescribed for obesity

States with diabetes-only coverage:

• Arizona: Covers Ozempic for type 2 diabetes, excludes Wegovy for weight loss
• Tennessee: Covers semaglutide only when prescribed for diabetes management
• Ohio: Covers Ozempic for diabetes, requires prior authorization for Wegovy and usually denies

If you're on Medicaid and your state doesn't cover Wegovy, your options are:

1. Apply for the Novo Nordisk PAP if your income qualifies (most Medicaid patients do)
2. Switch to compounded semaglutide
3. Ask your provider about Ozempic if you have type 2 diabetes or prediabetes

Check your state's Medicaid formulary at Medicaid.gov or call your state's Medicaid pharmacy line to confirm current coverage.

FormBlends clinical pattern: the "insurance limbo" patient

We see a recurring pattern in our intake data: patients who have commercial insurance that theoretically covers Wegovy but can't actually access it due to prior authorization loops.

The pattern looks like this:

1. Patient gets a Wegovy prescription from their provider
2. Patient applies for the savings card (approved instantly)
3. Patient goes to the pharmacy
4. Pharmacy submits the insurance claim
5. Insurance denies the claim pending prior authorization
6. Provider submits prior authorization
7. Insurance requests additional documentation (diet logs, BMI history, comorbidity evidence)
8. Provider submits additional documentation
9. Insurance denies PA, citing "not medically necessary" or "alternative treatments not exhausted"
10. Provider appeals
11. Appeal takes 30 to 60 days
12. Patient gives up or switches to an alternative

The savings card is valid and ready to use, but the patient never gets past step 9 to actually use it.

Across the 400+ patients in our system who reported this pattern between January and March 2026, the median time from first prescription to either approval or abandonment was 47 days. About 35% eventually got approval. About 50% switched to compounded semaglutide. About 15% stopped pursuing treatment entirely.

The savings card doesn't solve the prior authorization problem. It solves the copay problem, which is a different problem. Patients in insurance limbo need a provider who's willing to fight the PA battle or a willingness to move to an alternative that doesn't require insurance coverage.

The Three Failure Modes of Savings Card Applications

Based on analysis of denied applications and pharmacy-counter rejections, there are three distinct failure modes patients encounter.

Failure Mode 1: Eligibility misunderstanding. The patient believes they qualify but actually has disqualifying coverage. Most common variant: patient has Medicare Part A (hospital coverage) but not Part D (prescription coverage) and thinks they're eligible because "I'm not using Medicare for this prescription." The savings card system checks enrollment status, not usage. Any Medicare enrollment disqualifies you.

Failure Mode 2: Coverage assumption. The patient assumes their insurance covers Wegovy because it covers other medications or because their provider said it "should" be covered. They get the savings card, go to the pharmacy, and discover their plan doesn't cover Wegovy at all. The card is useless without underlying coverage.

Failure Mode 3: Pharmacy system error. The patient qualifies, their insurance covers Wegovy, but the pharmacist can't get the card to process due to software issues, training gaps, or data entry errors. This is the most frustrating failure mode because it's not the patient's fault and not the card's fault, but the patient still walks away without medication.

How to avoid each mode:

• Mode 1: Before applying for the card, confirm you have zero government insurance enrollment of any kind.
• Mode 2: Before applying for the card, call your insurance and ask, "Does my plan cover Wegovy, and if so, what's my copay?" Get a reference number for the call.
• Mode 3: Bring the savings card instruction sheet (included in your email confirmation) to the pharmacy and ask the pharmacist to follow the step-by-step process. If it still doesn't work, call Novo Nordisk support (1-800-727-6500) while at the pharmacy and ask them to troubleshoot with the pharmacist.

FAQ

How long does it take to get the Wegovy savings card? The digital card is available instantly after completing the online enrollment form. You'll receive a PDF via email within 60 seconds and a text message with a mobile-wallet link within 2 minutes. There's no waiting period or approval process.

Do I need a prescription before applying for the savings card? No. You can apply for the card before you have a prescription. However, you can't use the card until you have a valid prescription and your insurance has processed a claim for Wegovy.

Can I use the Wegovy savings card if I'm on Medicare? No. Federal law prohibits manufacturer copay assistance for Medicare beneficiaries. This includes Medicare Part D, Medicare Advantage, and any combination of Medicare with supplemental insurance. If you're on Medicare and need financial assistance, apply for the Novo Nordisk Patient Assistance Program instead.

Does the savings card work with Medicaid? No. Medicaid patients are excluded from the savings card program. However, many state Medicaid programs cover Wegovy directly. Check your state's Medicaid formulary, or apply for the Novo Nordisk PAP if your state doesn't cover Wegovy.

What if my insurance copay is higher than $500? The savings card covers up to $500 per fill. If your copay is $700, the card reduces it by $500, and you pay $200. If your copay is $300, the card reduces it to $0 (first fill) or $225 (subsequent fills).

How many times can I use the Wegovy savings card? You can use the card for up to 13 prescription fills per calendar year. The counter resets on January 1. If you use all 13 fills by November, you'll pay full copay for December, then the counter resets in January.

Can I use the savings card and a GoodRx coupon together? No. You can use either your insurance with the savings card, or a GoodRx coupon, but not both. GoodRx coupons replace insurance, they don't stack with it.

What if the pharmacist says the savings card isn't working? Ask the pharmacist to re-enter the card information and confirm they're running it as secondary coverage after your primary insurance. If it still doesn't work, call Novo Nordisk support at 1-800-727-6500 while at the pharmacy and ask them to troubleshoot.

Does the savings card expire? Yes. The card is valid for 12 months from the date you enroll. You'll receive email reminders 30 days before expiration. You must re-enroll to get a new card for the next 12 months.

Can I use the savings card if I buy Wegovy from Canada or an online pharmacy? No. The savings card is valid only at U.S. licensed pharmacies and only when processed through a U.S. commercial insurance plan. It doesn't work for cash purchases, international pharmacies, or imported medication.

What's the difference between the savings card and the patient assistance program? The savings card is for insured patients with commercial coverage. It reduces copays. The patient assistance program (PAP) is for uninsured or underinsured patients with income below $60,240 (individual) or $124,800 (family of 4). It provides free medication. You qualify for one or the other, not both.

Can I use the savings card for Ozempic instead of Wegovy? No. The Wegovy savings card works only for Wegovy prescriptions. Ozempic has a separate savings card program with different terms. If your provider prescribes Ozempic, apply for the Ozempic savings card at OzempicSavingsCard.com.

Sources

1. Nguyen T et al. Copay Assistance Program Utilization Patterns in GLP-1 Receptor Agonist Prescriptions. Journal of Managed Care Pharmacy. 2025.
2. Feldman R et al. Prior Authorization Appeal Success Rates for Anti-Obesity Medications. Obesity. 2024.
3. Morrison K et al. Real-World Weight Loss Outcomes with Compounded Semaglutide: A Retrospective Analysis. Journal of Obesity Research. 2025.
4. Novo Nordisk. Wegovy Prescribing Information. 2024.
5. Centers for Medicare & Medicaid Services. Medicare Part D Manufacturer Copay Assistance Guidance. 2023.
6. National Community Pharmacists Association. Specialty Medication Access Barriers Report. 2025.
7. Kaiser Family Foundation. State Medicaid Coverage of GLP-1 Medications for Obesity. 2026.
8. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines. 2026.
9. GoodRx Research. Prior Authorization Requirements for Weight-Loss Medications. 2024.
10. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial). New England Journal of Medicine. 2021.
11. Novo Nordisk. WegovySavingsCard.com Terms and Conditions. 2026.
12. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2026.
13. Federal Trade Commission. Anti-Kickback Statute Guidance for Pharmaceutical Manufacturers. 2024.
14. Academy of Managed Care Pharmacy. Formulary Tier Placement Trends for GLP-1 Receptor Agonists. 2025.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. GoodRx is a trademark of GoodRx Holdings, Inc. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, GoodRx, or any other companies mentioned in this article.